Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Prezista approved for pediatric use in Canada

Feb. 17, 2010

Merck & Co. discloses novel HIV integrase inhibitors

Feb. 17, 2010

HSV-2 suppression with acyclovir does not reduce risk for HIV-1 transmission

Feb. 15, 2010

Tibotec's Prezista approved in Canada as part of combination therapy for pediatric HIV

Feb. 10, 2010

Phase I data support safety and tolerability of ADMVA HIV candidate vaccine

Feb. 10, 2010

Avexa reports results from phase III study of apricitabine in drug-resistant HIV

Feb. 9, 2010

GeoVax presents update on development of 2-component HIV-1 vaccine

Feb. 9, 2010

Modest cellular immune responses seen with ADVAX HIV-1 candidate vaccine

Feb. 8, 2010

FDA approves labeling update for Tibotec's Prezista for HIV-1

Feb. 4, 2010

FDA reports safety risk associated with HIV drug Videx

Feb. 3, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...